Lavanya Athithan1, Amrit Chowdhary2, Daniel Swarbrick1, Gaurav S Gulsin1, Anvesha Singh1, Nicholas Jex2, Manali Jain2, Jamal N Khan1, Matthew P M Graham-Brown1, Joanne V Wormleighton1, Kelly S Parke1, Melanie J Davies3, Theodoros Karamitsos4, Kieran Clarke5, Stefan Neubauer4, Eylem Levelt6, Gerry P McCann1. 1. Department of Cardiovascular Sciences, University of Leicester and the Leicester NIHR Biomedical Research Centre, Leicester, UK. 2. Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire, UK. 3. Leicester Diabetes Centre, University of Leicester, Leicester, UK. 4. Radcliffe Department of Medicine, University of Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, University of Oxford, Oxford, Oxfordshire, UK. 5. Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, Oxfordshire, UK. 6. Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, West Yorkshire LS2 9JT.
Abstract
BACKGROUND: Type 2 diabetes (T2D) is associated with an increased risk of heart failure (HF) and cardiovascular mortality. A large-scale meta-analysis on HF found that diabetes was more frequent in women than men, and diabetes appeared to have attenuated the otherwise protective effect of female sex on progression of cardiomyopathy. The exact underlying mechanisms for this remain unclear. Here, we aimed to determine the effect of sex on the phenotypic expression of diabetic heart disease in patients with T2D. METHODS: A total of 62 male [mean age 44 ± 8 years, body mass index (BMI) 33 ± 5 kg/m2, mean HBA1c of 7.8 ± 1.8%] and 67 female (44 ± 10 years, BMI 35 ± 6 kg/m2, HBA1c 7.6 ± 1.2%) T2D patients on oral glucose-lowering treatment, and 16 male (48 ± 17 years, BMI 25 ± 3 kg/m2) and 14 female (50 ± 10 years, BMI 25 ± 4 kg/m2) controls were recruited. Left ventricular (LV) volumes, mass, function and deformation, and left atrial (LA) volumes and function were assessed using cardiac magnetic resonance imaging (CMR). RESULTS: Participants in all groups were of similar age, and there were no significant differences in blood pressure (BP), diabetes duration or metabolic profile between the two diabetes groups. Concentric remodeling was present in both sexes (p < 0.0001), with greater degree of concentric hypertrophy in males (12%, p = 0.0015). Biplane LA ejection fraction (LAEF) (p = 0.038), peak systolic circumferential strain (p < 0.0001) and diastolic strain rates (p = 0.001) were significantly reduced in men compared with women with T2D. There were no significant differences in biplane LAEF, peak systolic circumferential strain and diastolic strain rates in women with T2D compared with female controls. Whereas in women with T2D, glycaemic control was linked to LV contractile function, there was no such relationship in men with T2D. CONCLUSION: Male sex adversely affects the phenotypic expression of diabetic heart disease. The striking differences in the cardiac phenotype between male and female patients with T2D promote awareness of gender-specific risk factors in search of treatment and prevention of diabetes-associated HF. CONDENSED ABSTRACT: We aimed to determine the effect of sex on the phenotypic expression of diabetic heart disease in patients with T2D. While our findings support the notion that in T2D, male sex adversely affects the phenotypic expression of diabetic heart disease, this is in apparent conflict with the previous large-scale study showing diabetes attenuates the otherwise protective effect of female sex on progression of cardiomyopathy. Further longitudinal studies looking at gender differences in clinical outcomes in T2D patients are needed. These sex-related differences promote awareness of sex-specific risk factors in search of treatment and prevention of diabetes-associated HF.
BACKGROUND: Type 2 diabetes (T2D) is associated with an increased risk of heart failure (HF) and cardiovascular mortality. A large-scale meta-analysis on HF found that diabetes was more frequent in women than men, and diabetes appeared to have attenuated the otherwise protective effect of female sex on progression of cardiomyopathy. The exact underlying mechanisms for this remain unclear. Here, we aimed to determine the effect of sex on the phenotypic expression of diabetic heart disease in patients with T2D. METHODS: A total of 62 male [mean age 44 ± 8 years, body mass index (BMI) 33 ± 5 kg/m2, mean HBA1c of 7.8 ± 1.8%] and 67 female (44 ± 10 years, BMI 35 ± 6 kg/m2, HBA1c 7.6 ± 1.2%) T2D patients on oral glucose-lowering treatment, and 16 male (48 ± 17 years, BMI 25 ± 3 kg/m2) and 14 female (50 ± 10 years, BMI 25 ± 4 kg/m2) controls were recruited. Left ventricular (LV) volumes, mass, function and deformation, and left atrial (LA) volumes and function were assessed using cardiac magnetic resonance imaging (CMR). RESULTS: Participants in all groups were of similar age, and there were no significant differences in blood pressure (BP), diabetes duration or metabolic profile between the two diabetes groups. Concentric remodeling was present in both sexes (p < 0.0001), with greater degree of concentric hypertrophy in males (12%, p = 0.0015). Biplane LA ejection fraction (LAEF) (p = 0.038), peak systolic circumferential strain (p < 0.0001) and diastolic strain rates (p = 0.001) were significantly reduced in men compared with women with T2D. There were no significant differences in biplane LAEF, peak systolic circumferential strain and diastolic strain rates in women with T2D compared with female controls. Whereas in women with T2D, glycaemic control was linked to LV contractile function, there was no such relationship in men with T2D. CONCLUSION: Male sex adversely affects the phenotypic expression of diabetic heart disease. The striking differences in the cardiac phenotype between male and female patients with T2D promote awareness of gender-specific risk factors in search of treatment and prevention of diabetes-associated HF. CONDENSED ABSTRACT: We aimed to determine the effect of sex on the phenotypic expression of diabetic heart disease in patients with T2D. While our findings support the notion that in T2D, male sex adversely affects the phenotypic expression of diabetic heart disease, this is in apparent conflict with the previous large-scale study showing diabetes attenuates the otherwise protective effect of female sex on progression of cardiomyopathy. Further longitudinal studies looking at gender differences in clinical outcomes in T2D patients are needed. These sex-related differences promote awareness of sex-specific risk factors in search of treatment and prevention of diabetes-associated HF.
Authors: Laura Ernande; Ernst R Rietzschel; Cyrille Bergerot; Marc L De Buyzere; Frédéric Schnell; Laure Groisne; Michel Ovize; Pierre Croisille; Philippe Moulin; Thierry C Gillebert; Geneviève Derumeaux Journal: J Am Soc Echocardiogr Date: 2010-10-08 Impact factor: 5.251
Authors: Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray Journal: Circulation Date: 2013-12-17 Impact factor: 29.690
Authors: Eui-Young Choi; Boaz D Rosen; Veronica R S Fernandes; Raymond T Yan; Kihei Yoneyama; Sirisha Donekal; Anders Opdahl; Andre L C Almeida; Colin O Wu; Antoinette S Gomes; David A Bluemke; Joao A C Lima Journal: Eur Heart J Date: 2013-05-03 Impact factor: 29.983
Authors: Sarah Rosner Preis; Shih-Jen Hwang; Sean Coady; Michael J Pencina; Ralph B D'Agostino; Peter J Savage; Daniel Levy; Caroline S Fox Journal: Circulation Date: 2009-03-23 Impact factor: 29.690
Authors: Lucy E Hudsmith; Steffen E Petersen; Damian J Tyler; Jane M Francis; Adrian S H Cheng; Kieran Clarke; Joseph B Selvanayagam; Matthew D Robson; Stefan Neubauer Journal: J Magn Reson Imaging Date: 2006-08 Impact factor: 4.813
Authors: Abdulghani M Larghat; Peter P Swoboda; John D Biglands; Mark T Kearney; John P Greenwood; Sven Plein Journal: Eur Heart J Cardiovasc Imaging Date: 2014-08-12 Impact factor: 6.875
Authors: Ankur Gulati; Tevfik F Ismail; Andrew Jabbour; Nizar A Ismail; Kishen Morarji; Aamir Ali; Sadaf Raza; Jahanzaib Khwaja; Tristan D H Brown; Emmanouil Liodakis; Arun J Baksi; Rameen Shakur; Kaushik Guha; Michael Roughton; Ricardo Wage; Stuart A Cook; Francisco Alpendurada; Ravi G Assomull; Raad H Mohiaddin; Martin R Cowie; Dudley J Pennell; Sanjay K Prasad Journal: Eur J Heart Fail Date: 2013-03-08 Impact factor: 15.534